{'text': 'New recruit has big dreams for cancer immunotherapy', 'publisher': {'href': 'https://www.novartis.com', 'title': 'Novartis'}, 'created_at': 'Mon, 30 Mar 2015 07:00:00 GMT', 'description': 'New recruit has big dreams for cancer immunotherapy  Novartis', 'url': 'https://news.google.com/rss/articles/CBMihwFBVV95cUxORVB5YXpCelJSMkhtWHl3VlFiUHZPS21yT29seTBzZXVmQkdqNS1QRW1nRlJPb0E5aHFpVVpNRWJ5TkJJYjl0S1UyZ2ZpS0tEU0VyM1EwTjdPcU1lVjExMHQwalA4bkhJa0VzNjJOTWxnbkZPcldtMzdmUW95WjZjMVV1ZEY3VjA?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': 'Novartis announces FDA approval for JadenuTM to simplify treatment administration for patients with chronic iron overload', 'publisher': {'href': 'http://www.multivu.com', 'title': 'MultiVu'}, 'created_at': 'Mon, 30 Mar 2015 07:00:00 GMT', 'description': 'Novartis announces FDA approval for JadenuTM to simplify treatment administration for patients with chronic iron overload  MultiVu', 'url': 'https://news.google.com/rss/articles/CBMiggFBVV95cUxNc2JINDBVU0ZfTDZyODNCMXhhY25JQ2Zzc1lBbU1sZ1Bwd193MGllNEtaOGdiV2pCNEphanBTTDY4NVlxa3JIOU5ocWV3OVBOVS1tSlA3TDlxekFhc3RtS2ZsRjNLZmZlY0Z5NXE4VHFRRDNnVGNlV0JLX1VBNk1Xalln?oc=5&hl=en-US&gl=US&ceid=US:en'}
